In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Partec GmbH

Division of Sysmex Corp.
www.partec.com

Latest From Partec GmbH

Device/Diagnostics Quarterly Deal Statistics, Q3 2013

Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.

Medical Device Deals

Deals Shaping The Medical Industry, November 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.

BioPharmaceutical Medical Device

Going With the Flow

In the in vitro diagnostics world, flow cytometry is a highly specialized, labor intensive niche, aimed at sophisticated analysis of intact whole cells. Dako Cytomation was formed in July to try to make inroads into this field, which some see as an area poised for growth. The merger of Dako and Cytomation, however, has infuriated Dako's former partner, Partec, a small German company focused on industrial applications of flow. Partec, however, is coming up with a new strategy for expanding its limited presence in human healthcare.
Medical Device Clinical Trials

An Intelligent Evolution for Dako and Cytomation

The Dako-Cytomation merger gives both companies things they've wanted for some time. Denmark-based Dako, a leading global supplier of IHC reagents and systems, gets a solid instrument platform and a stronger presence in the US. US-based Cytomation, an aggressive maker of high-speed flow cytometry instruments, gets a world-class marketing partner and a high-quality reagent house. The businesses complement each other, with almost no redundancies, say both companies' CEOs.
Medical Device Strategy
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Sysmex Corp.
  • Senior Management
  • Contact Info
  • Partec GmbH
    Phone: (49) 2534 8008 0
    Otto-Hahn-Str. 32
    Munster, 48161
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register